Cover Image
Market Research Report

Regenerative Medicine Market by Therapy (Cell Therapy, Tissue Engineering, Immunotherapy, Gene Therapy), Product (Cell-Based, Acellular), Applications (Orthopedic & Musculoskeletal Disorders, Dermatology, Oncology, Cardiology) - Forecast to 2021

Published by MarketsandMarkets Product code 363089
Published Content info 140 Pages
Immediate Delivery Available
Price
Back to Top
Regenerative Medicine Market by Therapy (Cell Therapy, Tissue Engineering, Immunotherapy, Gene Therapy), Product (Cell-Based, Acellular), Applications (Orthopedic & Musculoskeletal Disorders, Dermatology, Oncology, Cardiology) - Forecast to 2021
Published: February 10, 2017 Content info: 140 Pages
Description

Title: Regenerative Medicine Market by Therapy (Cell Therapy, Tissue Engineering, Immunotherapy, Gene Therapy), By Product (Cell-Based, Acellular), By Applications (Orthopedic & Musculoskeletal Disorders, Dermatology, Oncology, Cardiology)-Forecast To 2021.

"The global Regenerative medicine market is expected to reach USD 38.70 billion by 2021 from USD 13.41 billion in 2016 at a CAGR of 23.6% from 2016 to 2021."

The major factor driving the growth of regenerative medicine market, are government and private funding to support the development of regenerative medicine, rising prevalence of chronic diseases and genetic disorders, increase in global healthcare expenditure, and rapid growth in the aging population.

The global Regenerative medicine market is segmented based on type, therapy, application, and regions. The cell-based products segment is expected to register to have largest market share in the Regenerative medicine market, by type, during the forecast period. The high growth in this segment is attributed to the increasing awareness about stem cell therapy, growing funding for new stem cell lines, and development of advanced genomic methods.

On the basis of therapy, the cell therapy procedure is expected to account for the largest share of the market in 2016. Increasing funding from several agencies and private organizations for the research and development of cell therapies, growing inclination of the healthcare industry towards stem cell research, and increasing global awareness about the benefits of stem cell therapies will drive the growth of this market.

On the basis of applications, the segments are orthopedic & musculoskeletal disorders, dermatology, cardiology, diabetes, central nervous system diseases, and other applications. Oncology is the fastest growing application market. Increasing cancer incidence, rich product pipeline and increasing demand for cancer treatments fuelling the growth of the market.

Geographically, the Regenerative medicine market is dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). Growth in the North American segment is primarily driven by rapidly increasing aging population and increase in chronic diseases are the major drivers for developed economies like the U.S.

The key players in the cell-based products segment are Organogenesis Inc. (U.S.), Osiris Therapeutics, Inc. (U.S.), Vericel Corporation (U.S.), Stryker Corporation (U.S.), and NuVasive, Inc. (U.S.). The key players in the acellular products segment are Medtronic (Ireland), Acelity (KCI Concepts) (U.S.), Integra LifeSciences (U.S.), Cook Biotech Inc. (U.S.), and C.R. Bard (U.S.).

Research Coverage:

The report analyses the Regenerative medicine market by type, therapy, application and regions. Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The above-mentioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the Regenerative medicine market.

Reasons to Buy the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the Regenerative medicine market.
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the Regenerative medicine market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the Regenerative medicine market
  • Market Development: Comprehensive information about emerging markets. This report analyses the market for various Regenerative medicine market products across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Regenerative medicine market.
Table of Contents
Product Code: BT 4419

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.3. MARKET SHARE ESTIMATION
    • 2.3.1. KEY DATA FROM SECONDARY SOURCES
    • 2.3.2. KEY DATA FROM PRIMARY SOURCES
    • 2.3.3. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. REGENERATIVE MEDICINE: MARKET OVERVIEW
  • 4.2. GEOGRAPHIC ANALYSIS: REGENERATIVE MEDICINE MARKET, BY THERAPY, 2016
  • 4.3. GEOGRAPHICAL SNAPSHOT OF THE REGENERATIVE MEDICINE MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
  • 5.3. DRIVERS
    • 5.3.1. GOVERNMENT & PRIVATE FUNDING TO SUPPORT THE DEVELOPMENT OF REGENERATIVE MEDICINE
    • 5.3.2. RISING PREVALENCE OF CHRONIC DISEASES AND GENETIC DISORDERS
    • 5.3.3. INCREASE IN GLOBAL HEALTHCARE EXPENDITURE
    • 5.3.4. RAPID GROWTH IN THE AGING POPULATION
    • 5.3.5. INCREASE IN CORPORATE PARTNERSHIPS TO ACCELERATE DEVELOPMENT AND COMMERCIALIZATION OF REGENERATIVE MEDICINE
  • 5.4. RESTRAINTS
    • 5.4.1. ETHICAL CONCERNS WITH THE USE OF EMBRYONIC STEM CELL FOR R&D
    • 5.4.2. LACK OF CLEAR REGULATORY GUIDELINES
  • 5.5. OPPORTUNITIES
    • 5.5.1. RISING DEMAND FOR ORGAN TRANSPLANTATION
    • 5.5.2. STRONG PRODUCT PIPELINE

6. GLOBAL REGENERATIVE MEDICINE MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. CELL-BASED PRODUCTS
    • 6.2.1. ALLOGENEIC PRODUCTS
    • 6.2.2. AUTOLOGOUS PRODUCTS
  • 6.3. ACELLULAR PRODUCTS

7. GLOBAL REGENERATIVE MEDICINE MARKET, BY THERAPY

  • 7.1. INTRODUCTION
  • 7.2. CELL THERAPY
  • 7.3. TISSUE ENGINEERING
  • 7.4. IMMUNOTHERAPY
  • 7.5. GENE THERAPY

8. REGENERATIVE MEDICINE MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. ORTHOPEDIC & MUSCULOSKELETAL DISORDERS
  • 8.3. DERMATOLOGY
  • 8.4. CARDIOLOGY
  • 8.5. CENTRAL NERVOUS SYSTEM DISEASES
  • 8.6. ONCOLOGY
  • 8.7. DIABETES
  • 8.8. OTHER APPLICATIONS

9. GLOBAL REGENERATIVE MEDICINE MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. U.S.
    • 9.2.2. CANADA
  • 9.3. EUROPE
    • 9.3.1. GERMANY
    • 9.3.2. U.K.
    • 9.3.3. FRANCE
    • 9.3.4. ITALY
    • 9.3.5. SPAIN
    • 9.3.6. REST OF EUROPE (ROE)
  • 9.4. ASIA-PACIFIC
  • 9.5. REST OF THE WORLD (ROW)

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. MARKET RANKING
  • 10.3. COMPETITIVE SITUATION AND TRENDS
    • 10.3.1. ACQUISITIONS
    • 10.3.2. PARTNERSHIPS
    • 10.3.3. REGULATORY APPROVALS
    • 10.3.4. NEW PRODUCT DEVELOPMENTS
    • 10.3.5. OTHERS

11. COMPANY PROFILES (Overview, Financial*, Products & Services, Strategy, and Developments)

  • 11.1. ACELITY L.P. INC. (KCI LICENSING)
  • 11.2. NUVASIVE, INC.
  • 11.3. VERICEL CORPORATION
  • 11.4. OSIRIS THERAPEUTICS, INC.
  • 11.5. INTEGRA LIFESCIENCES CORPORATION
  • 11.6. STRYKER CORPORATION
  • 11.7. MEDTRONIC PLC
  • 11.8. COOK BIOTECH INCORPORATED
  • 11.9. ORGANOGENESIS INC.
  • 11.10. JAPAN TISSUE ENGINEERING CO., LTD. (SUBSIDIARY OF FUJIFILM HOLDINGS CORPORATION)

*Details might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. INSIGHTS FROM INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.5. AVAILABLE CUSTOMIZATIONS
  • 12.6. RELATED REPORTS
  • 12.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: KEY CORPORATE PARTNERSHIPS, 2016
  • TABLE 2: GENE THERAPY PRODUCTS IN CLINICAL TRIALS, 2016
  • TABLE 3: CELL AND GENE THERAPY CLINICAL PRODUCT PIPELINE, 2016
  • TABLE 4: GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
  • TABLE 5: CELL-BASED PRODUCTS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 6: CELL-BASED PRODUCTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 7: ALLOGENEIC PRODUCTS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 8: AUTOLOGOUS PRODUCTS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 9: ACELLULAR PRODUCTS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 10: GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY, 2014-2021 (USD BILLION)
  • TABLE 11: STEM CELL THERAPIES IN PHASE III DEVELOPMENT, 2016
  • TABLE 12: CELL THERAPY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 13: TISSUE ENGINEERING MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 14: IMMUNOTHERAPY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 15: GENE THERAPIES IN CLINICAL TRIALS, 2016
  • TABLE 16: GENE THERAPY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 17: NUMBER OF CLINICAL TRIALS FOR REGENERATIVE MEDICINE, BY THERAPEUTIC CATEGORY (2016)
  • TABLE 18: NUMBER OF CLINICAL TRIALS FOR REGENERATIVE MEDICINE, BY PHASE (2016)
  • TABLE 19: REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 20: ORTHOPEDIC & MUSCULOSKELETAL DISORDERS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 21: DERMATOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 22: CARDIOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 23: CENTRAL NERVOUS SYSTEM DISEASES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 24: CANCER PATIENTS (GLOBAL), BY CANCER TYPE, 2015-2035
  • TABLE 25: ONCOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 26: DIABETES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 27: OTHER APPLICATIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 28: GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 29: NORTH AMERICA: REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 30: NORTH AMERICA: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
  • TABLE 31: NORTH AMERICA: CELL-BASED PRODUCTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 32: NORTH AMERICA: REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 33: NORTH AMERICA: REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY, 2014-2021 (USD BILLION)
  • TABLE 34: U.S.: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
  • TABLE 35: U.S.: CELL-BASED PRODUCTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 36: U.S.: REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 37: U.S.: REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY, 2014-2021 (USD BILLION)
  • TABLE 38: CANADA: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
  • TABLE 39: CANADA: CELL-BASED PRODUCTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 40: CANADA: REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 41: CANADA: REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY, 2014-2021 (USD BILLION)
  • TABLE 42: EUROPE: REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 43: EUROPE: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
  • TABLE 44: EUROPE: CELL-BASED PRODUCTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 45: EUROPE: REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 46: EUROPE: REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY, 2014-2021 (USD BILLION)
  • TABLE 47: GERMANY: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
  • TABLE 48: GERMANY: CELL-BASED PRODUCTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 49: GERMANY: REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 50: GERMANY: REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY, 2014-2021 (USD BILLION)
  • TABLE 51: U.K.: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
  • TABLE 52: U.K.: CELL-BASED PRODUCTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 53: U.K.: REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 54: U.K.: REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY, 2014-2021 (USD BILLION)
  • TABLE 55: FRANCE: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
  • TABLE 56: FRANCE: CELL-BASED PRODUCTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 57: FRANCE: REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 58: FRANCE: REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY, 2014-2021 (USD BILLION)
  • TABLE 59: ITALY: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
  • TABLE 60: ITALY: CELL-BASED PRODUCTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 61: ITALY: REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 62: ITALY: REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY, 2014-2021 (USD BILLION)
  • TABLE 63: SPAIN: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
  • TABLE 64: SPAIN: CELL-BASED PRODUCTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 65: SPAIN: REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 66: SPAIN: REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY, 2014-2021 (USD BILLION)
  • TABLE 67: ROE: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
  • TABLE 68: ROE: CELL-BASED PRODUCTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 69: ROE: REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 70: ROE: REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY, 2014-2021 (USD BILLION)
  • TABLE 71: ASIA-PACIFIC: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
  • TABLE 72: ASIA: CELL-BASED PRODUCTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 73: ASIA-PACIFIC: REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 74: ASIA-PACIFIC: REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY, 2013-2021 (USD BILLION)
  • TABLE 75: ROW: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
  • TABLE 76: ROW: CELL-BASED PRODUCTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 77: ROW: REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 78: ROW: REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY, 2014-2021 (USD BILLION)
  • TABLE 79: RANKING OF MAJOR PLAYERS IN THE GLOBAL CELL-BASED REGENERATIVE MEDICINE MARKET (2015)
  • TABLE 80: RANKING OF MAJOR PLAYERS IN THE GLOBAL ACELLULAR REGENERATIVE MEDICINE MARKET (2015)
  • TABLE 81: KEY PRODUCTS IN THE CELL-BASED REGENERATIVE MEDICINE MARKET (2015)
  • TABLE 82: KEY PRODUCTS IN THE ACELLULAR REGENERATIVE MEDICINE MARKET (2015)
  • TABLE 83: ACQUISITIONS, 2014-2017
  • TABLE 84: PARTNERSHIPS, 2014-2016
  • TABLE 85: REGULATORY APPROVALS, 2014-2016
  • TABLE 86: NEW PRODUCT DEVELOPMENTS, 2013-2016
  • TABLE 87: OTHERS, 2014-2016

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 3: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: CELL-BASED PRODUCTS TO LEAD THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 7: CELL THERAPY TO DOMINATE THE REGENERATIVE MEDICINE MARKET BY 2021
  • FIGURE 8: GLOBAL REGENERATIVE MEDICINE MARKET, BY APPLICATION, 2016 VS. 2021
  • FIGURE 9: NORTH AMERICA TO LEAD THE REGENERATIVE MEDICINE MARKET DURING THE FORECAST PERIOD
  • FIGURE 10: GLOBAL REGENERATIVE MEDICINE MARKET TO REGISTER HIGH, DOUBLE-DIGIT GROWTH FROM 2016 TO 2021
  • FIGURE 11: CELL THERAPY SEGMENT TO DOMINATE THE REGENERATIVE MEDICINE MARKET IN 2016
  • FIGURE 12: ASIA-PACIFIC TO BE THE FASTEST-GROWING REGION IN THE FORECAST PERIOD
  • FIGURE 13: GLOBAL REGENERATIVE MEDICINE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 14: GLOBAL REGENERATIVE MEDICINE MARKET SEGMENTATION, BY PRODUCT
  • FIGURE 15: CELL-BASED PRODUCTS TO COMMAND THE LARGEST SHARE OF THE GLOBAL REGENERATIVE MEDICINE MARKET IN 2016
  • FIGURE 16: CELL-BASED PRODUCTS MARKET SEGMENTATION, BY TYPE
  • FIGURE 17: CELL THERAPY TO DOMINATE THE REGENERATIVE MEDICINE MARKET DURING THE FORECAST PERIOD
  • FIGURE 18: ORTHOPEDIC & MUSCULOSKELETAL DISORDERS SEGMENT TO DOMINATE THE REGENERATIVE MEDICINE APPLICATIONS MARKET IN 2016
  • FIGURE 19: NUMBER OF DIABETES CASES, 2015 VS. 2040 (MILLION)
  • FIGURE 20: NORTH AMERICA: REGENERATIVE MEDICINE MARKET SNAPSHOT
  • FIGURE 21: NORTH AMERICA: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
  • FIGURE 22: U.S.: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
  • FIGURE 23: EUROPE: REGENERATIVE MEDICINE MARKET SNAPSHOT
  • FIGURE 24: EUROPE: REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY, 2014-2021 (USD BILLION)
  • FIGURE 25: GERMANY: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
  • FIGURE 26: ASIA-PACIFIC: REGENERATIVE MEDICINE MARKET SNAPSHOT
  • FIGURE 27: ASIA-PACIFIC.: REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
  • FIGURE 28: REST OF THE WORLD: REGENERATIVE MEDICINE MARKET SNAPSHOT
  • FIGURE 29: ROW: REGENERATIVE MEDICINE MARKET SIZE, BY THERAPY, 2014-2021 (USD BILLION)
  • FIGURE 30: LEADING MARKET PLAYERS ADOPTED BOTH ORGANIC AND INORGANIC GROWTH STRATEGIES OVER THE LAST FOUR YEARS (2013-2017)
  • FIGURE 31: BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES & PRODUCT ENHANCEMENTS ARE THE KEY STRATEGIES
  • FIGURE 32: ACELITY (KCI LICENSING): COMPANY SNAPSHOT (2015)
  • FIGURE 33: NUVASIVE, INC.: COMPANY SNAPSHOT (2015)
  • FIGURE 34: VERICEL CORPORATION: COMPANY SNAPSHOT (2015)
  • FIGURE 35: OSIRIS THERAPEUTICS, INC.: COMPANY SNAPSHOT (2014)
  • FIGURE 36: INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2015)
  • FIGURE 37: MEDTRONIC PLC: COMPANY SNAPSHOT (2016)
  • FIGURE 38: JAPAN TISSUE ENGINEERING CO., LTD: COMPANY SNAPSHOT (2015)
Back to Top